Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Inventory (2020 - 2025)

Historic Inventory for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $2.6 million.

  • Celularity's Inventory fell 3532.68% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 3532.68%. This contributed to the annual value of $5.4 million for FY2024, which is 597.95% down from last year.
  • According to the latest figures from Q3 2025, Celularity's Inventory is $2.6 million, which was down 3532.68% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Inventory ranged from a high of $24.7 million in Q2 2022 and a low of $2.6 million during Q3 2025
  • For the 5-year period, Celularity's Inventory averaged around $6.8 million, with its median value being $5.4 million (2024).
  • In the last 5 years, Celularity's Inventory tumbled by 7673.44% in 2023 and then skyrocketed by 6744.12% in 2025.
  • Over the past 5 years, Celularity's Inventory (Quarter) stood at $9.5 million in 2021, then crashed by 44.41% to $5.3 million in 2022, then rose by 8.38% to $5.8 million in 2023, then dropped by 5.98% to $5.4 million in 2024, then crashed by 52.62% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $4.4 million for Q2 2025, and $6.2 million during Q1 2025.